Perioperativ relavante Störungen des Flüssigkeits-und Elektrolythaushaltes

  • H. Gombotz
Chapter

Zusammenfassung

Schrittmacherpatienten leiden meist an koronarer Herzkrankheit, Kardiomyopathie, peripheren Gefäßerkrankungen, Hypertonie oder Diabetes mellitus und stehen fast immer unter Dauermedikation (z.B. Glykoside und Antiarrhythmika). Für den Anästhesisten besteht das Hauptproblem normalerweise nicht im Schrittmachersystem, sondern in der für das Anästhesierisiko bestimmenden Grundkrankheit und dem oft sehr hohen Alter der Schrittmacherpatienten. Ein präoperativ funktionierender Schrittmacher dürfte normalerweise bei Beachtung aller Vorsichtsmaßnahmen intraoperativ keine Probleme bringen. Unter bestimmten Bedingungen können jedoch in der perioperativen Phase auch präoperativ intakte Schrittmachersysteme gestört werden und z.T. lebensbedrohliche Komplikationen verursachen.

This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Andersen C, Madsen GM (1990) Rate-responsive pacemakers and anaesthesia. Anaesthesia 45: 472PubMedCrossRefGoogle Scholar
  2. Asroff SW, Kingston TE, Stein BS (1993) Extracorporeal shock wave lithotripsy in patients with cardiac pacemaker in an abdominal location: case report and review of the literature. J Endourol 7: 189–92PubMedCrossRefGoogle Scholar
  3. Aylward P, Blood R, Tonkin A (1979) Complications of defibrillation with permanent pacemaker in situ. Pace 2: 462PubMedCrossRefGoogle Scholar
  4. Bernstein AD, Camm J, Fischer D et al. (1993) The NASPE/BPEG Defibrillator Code. Pace 16: 1776PubMedCrossRefGoogle Scholar
  5. Block M, Hammel D, Borggrefe M, Scheid HH, Breithard G (1994) Transvenöse subkutane Implantationstechnik von Defibrillatoren. Herz 19: 259PubMedGoogle Scholar
  6. Brodman R, Fischer JD, Johnston DR et al. (1984) Results of electrophysiologically guided operations for drug-resistant recurrent ventricular fibrillation due to coronary artery disease. J Thorac Cardiovasc Surg 87:431PubMedGoogle Scholar
  7. Büchner C, Drägert W (1973) Schrittmacher-Therapie des Herzens. Forum cardiologicum 14. Boehringer, MannheimGoogle Scholar
  8. Domino KB, Smith TC (1983) Electrocautery — induced reprogramming of a pacemaker using a precordial magnet. Anesth Analg 62: 609PubMedCrossRefGoogle Scholar
  9. Erbel R (1979) Pacemaker syndrom. Am J Cardiol 44: 771PubMedCrossRefGoogle Scholar
  10. Forand JM, Schweiss JF (1984) Pacemaker syndrom during anesthesia. Anesthesiology 60: 588PubMedCrossRefGoogle Scholar
  11. Frommer M, Brackmann J, Block M et al. (1992) Efficiacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing-cardioverter-defibrillator. Results of a European multicenter study of 102 implants. Circulation 86: 363Google Scholar
  12. Gaba DM, Wyner J, Fish KJ (1985) Anesthesia and the automatic implantable cardioverter/defibrillator. Anesthesiology 62: 786PubMedCrossRefGoogle Scholar
  13. Gams E, Feder E, Heimisch W (1978) Externe Störbeeinflussung von Herzschrittmachern. Herz 3: 367Google Scholar
  14. Gombotz H, Knolz M, Rehak P, Tscheliessnigg KH, Dacar D (1985) Auswirkungen von Ketamin, Halothan, Enfluran und Isofluran auf die endomyokardiale Reizschwelle. Anaesthesist 34 Suppl: 286Google Scholar
  15. Grayboys TB, Lown B, Podfied PJ et al. (1982) Long term survival of patients with malignant ventricular arrhythmias with antiarrhythmic drugs. Am J Cardiol 50: 437CrossRefGoogle Scholar
  16. Hughes HC, Tyers GFO, Toman HA (1975) Effects of acid-base imbalance on myocardial pacing tresholds. J Thorac Cardiovasc Surg 69: 743PubMedGoogle Scholar
  17. Irnich W (1982) Störbeeinflussung von Herzschrittmachern, Herzschrittmacher 2: 4Google Scholar
  18. Kaden F (1984) Akuter Herzkreislaufstillstand infolge Schrittmacherrasens als lebensgefährliche Komplikation bei Einsatz eines Thermokauters. Herzschrittmacher 4: 150Google Scholar
  19. Kelly PA, Cannom DS, Garan H et al. (1988) The automatic implantable cardioverter/defibrillator (AICD): Efficacy, complications and survival in patients with malignant ventricular arrhythmias. J Am Coll Cardiol 11: 1278PubMedCrossRefGoogle Scholar
  20. Keyl C, Tassani P, Kemkes B, Markewitz A, Hofmann E, Steinbeck G (1993) Hemodynamic changes due to intraoperative testing of the automatic implantable cardioverter defibrillator: Implications for anesthesia management. J Cardiothorac Vasc Anesth 7: 442PubMedCrossRefGoogle Scholar
  21. Madigan JD, Choudrhri AF, Chen J, Spotnitz HM, Oz MC, Edwards N (1999) Surgical management of the patient with an implanted cardiac device: implications of electromagnetic interference. Ann Surg 230: 639–647PubMedCrossRefGoogle Scholar
  22. Mangar D, Atlas GM, Kane PB (1991) Electrocauteryinduced pacemaker malfunction during surgery. Can J Anaesth 38: 616PubMedCrossRefGoogle Scholar
  23. Mond HG (1991) Unipolar versus bipolar pacing — poles apart. Pace 14: 1411PubMedCrossRefGoogle Scholar
  24. O’Reilly MV, Murnaghan DP, Williams MB (1974) Transvenous pacemaker failure induced by hyperkalemia. JAMA 228: 336CrossRefGoogle Scholar
  25. Parsonnet V, Furmann S, Smith NPD (1981) A revised code for pacemaker identification. Pace 4: 400PubMedCrossRefGoogle Scholar
  26. Preston TA, Judge RD (1969) Alteration of pacemaker threshold by drug and physiological factors. Ann NY Acad Sci USA 167: 686CrossRefGoogle Scholar
  27. Reiffei JA, Cormilas J, Zimmermann JM et al. (1985) Drug-device interactions — Clinical considerations. Pace 8: 369CrossRefGoogle Scholar
  28. Riper DF, Horrow JC, Kutalek SP, McCormick D, Goldman SM (1990) Mixed venous oximetry during automatic implantable cardioverter-defibrillator placement. J Cardiothorac Vasc Anesth 4: 453CrossRefGoogle Scholar
  29. Rozanski JJ, Blankenstein RL, Lister JW (1983) Pacer arrhythmias: Myopotential triggering of pacemaker mediated tachycardia. Pace 6: 795PubMedCrossRefGoogle Scholar
  30. Ruffly R, Schectuman K, Monje E et al. (1986) Adrenergically mediated variations in the energy required to defibrillate the heart — observations in clost chest, non anesthetized dogs. Circulation 73: 374CrossRefGoogle Scholar
  31. Schaldach M (1992) Current status of pacemaker technology. In: Atlee JL, Gombotz H, Tscheliessnigg KH (Hrsg) Perioperative management of pacemaker patients. Springer, Berlin Heidelberg New York Tokyo, S 1CrossRefGoogle Scholar
  32. Schlegel H, Seipel L, Böhminghaus F (1981) Funktionsstörungen von Demand-Schrittmachern bei urologischen Operationen mittels Elektokauter. Z Kardiol 70: 803Google Scholar
  33. Shellok FG, O’Neill M, Ivans V, Kelly D, o’Connor M, Toay L, Crues JV (1999) Cardiac pacemakers and implantable cardioverter defibrillator are unaffected by operation of an extremity MR imaging system. Am J Roentgenol 172: 165–170Google Scholar
  34. Simon AB (1977) Perioperative management of the pacemaker patient. Anesthesiology 46: 127PubMedCrossRefGoogle Scholar
  35. Steckmeier J, Schaudig A, Zimmermann M, Welter HW, Thetter O (1984) Störung der Schrittmacherfunktion durch Muskelpotentiale bei uniund bipolaren VVI-Systemen sowie unipolarer Zweikammerstimulation. Z Herzschrittmacher 4: 254Google Scholar
  36. Steilner H, Maisch B (1985) Der Schrittmacherpatient im Alltag. Herz Gefäße 5: 580Google Scholar
  37. Troup PM, Chapman PD, Olinger GN (1985) The implanted defibrillator: Relation of defibrillation thresholds. J Am Coll Cardiol 6: 1315PubMedCrossRefGoogle Scholar
  38. Tscheliessnigg KH, Gombotz H, Atlee JL (1992) Guidelines for the perioperative management of pacemaker and automatic internal cardioverterdefibrillator patients. In: Atlee JL, Gombotz H, Tscheliessnigg KH (Hrsg) Perioperative management of pacemaker patients. Springer, Berlin Heidelberg New York Tokyo, S 146CrossRefGoogle Scholar
  39. Westerholm CJ (1971) Threshold studies in transvenous cardiac pacemaker treatment. Scand J Thorac Cardiovasc Surg Suppl 8: 1Google Scholar
  40. Zaidan JR, Curling PE, Craver JM (1985) Effect of enfluran, isofluran and halothan in pacing stimulation threshold in man. Pace 8: 32PubMedCrossRefGoogle Scholar
  41. Atlee JL, Combotz H, Tscheliessnigg KH (1992) Perioperative management of pacemaker patients. Springer, Berlin Heidelberg New York TokyoCrossRefGoogle Scholar
  42. Bourke ME (1996) The patient with a pacemaker or related device. Can J Anaesth 43: 5 R24–R32PubMedCrossRefGoogle Scholar
  43. Deutsch N, Hantier CB, Morady F, Kirsh M (1990) Perioperative management of the patients undergoing automatic internal cardioverter-defibrillator implantation. J Cardiothorac Vasc Anesth 4: 236CrossRefGoogle Scholar
  44. Kemnitz J, Peters J (1993) Herzschrittmacher und implantierbare Kardioverter-Defibrillatoren in der perioperativen Phase. Anästhesiol Intensivmed Notfallmed Schmerzther 28: 199–212PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • H. Gombotz
    • 1
  1. 1.Universitätsklinik für Anästhesiologie und Intensivmedizin LKH Universitätsklinikum GrazGraz

Personalised recommendations